On Campus Online
News
zinkernagel

“Forefather” of immunology visits U of C


zinkernagel in HSCBy Rebecca Eras

When Dr. Rolf Zinkernagel visited the University of Calgary’s Faculty of Medicine earlier this month, Dr. Paul Kubes, director of the Institute of Infection, Immunity and Inflammation, compared it to a physics student meeting Albert Einstein.

“Much of Dr. Zinkernagel’s work forms the foundation for immunology,” said Kubes. “He’s created the springboard that allows us to advance our own studies.”

Zinkernagel, a Nobel Prize winner working on emerging viral diseases, gave a presentation in the Libin Lecture Theatre on Feb. 12. The head of the Institute of Experimental Immunology at the University of Zürich, Switzerland, he spoke about his work on antiviral antibody responses.

The U of C was one of only three Canadian stops Zinkernagel made before returning to Switzerland. His visit provided students an opportunity to meet the man they’ve read about in their textbooks. It also granted scientists an opportunity to question him about the projects they’ve been working on, so he could share his knowledge of possible applications to the big picture.

“The opportunity to meet with a forefather in immunology during my studies here at U of C only serves to strengthen my passion and resolve for completing my degree at an institution of such high calibre,” said student Lisa Nelson.

Zinkernagel earned the 1996 Nobel Prize in physiology or medicine with partner Dr. Peter Doherty for their breakthrough work in understanding how our immune system distinguishes natural cells from foreign ones, a process known as minor histocompatibility complex (MHC) restriction.

Their groundbreaking work formed the basis of immunology by discovering the mechanisms that allow the immune system to recognize foreign material.

Zinkernagel’s presentation focused on the nature of antibodies and why it’s so difficult to vaccinate for some viruses and not others. He explained that viruses evolve and mutate, thereby making it difficult to control their spread. For instance, the human immunodeficiency virus (HIV)—considered a new virus—inhibits the body’s ability to recognize the virus, so the body doesn’t have the capacity to fight it. Our bodies are able to recognize other viruses and have built up enough resistance to them to coexist.

VOLUME 3, ISSUE 6
FEBRUARY 2007

FRONT PAGE

NEWS

Build your U

New dean of medicine

Helping small towns

AHFMR Polaris award

Student elections

Experts Online

Nobel winner talks

RESEARCH

Hope for MS cure

Origins of farming

Prion Lab

Red hot research

Chimps had hammers

LEARNING CURVES

Learn by doing

Nominate a great teacher

EVENTS FOR YOU

Playing second fiddle

Shell Oil opens doors

Science Cafe

YOUR ALUMNI

Second language learning

POSTCARD

... from Germany

 

 

Sound Off!
University of Calgary